Product Information
METHYLPREDNISOLONE 4 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1240 per EA under NDC 62135076001. Its NADAC has been published 102 times since Sep 11, 2024.
FDA first approved this application on Feb 22, 2019.
Strength
4 mg/1
Manufacturer
Chartwell RX LLCNDC
62135076001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLPREDNISOLONEApproval Type
Generic (ANDA)
FDA Application
ANDA209097FDA Approved
2/22/2019
On Market Since
2/22/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPREDNISOLONE 4 MG TABLET has been published 102 times since Sep 11, 2024, and over the history we have for it it has declined 24.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1240 per EA |
|---|---|
| All-time high | $0.1634 (Sep 11, 2024) |
| All-time low | $0.1105 (Nov 20, 2024) |
| 52-week high | $0.1606 |
| 52-week low | $0.1211 |
| Median price | $0.1413 |
| Average price | $0.1392 |
| Largest weekly change | -25.0% (Nov 20, 2024) |
| Weeks tracked | 102 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPREDNISOLONE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 4 MG TABLET, manufactured by Chartwell RX LLC, is $0.1240 per EA (NDC 62135076001), effective Aug 19, 2026.
How has the price of METHYLPREDNISOLONE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPREDNISOLONE 4 MG TABLET has declined 24.1%. It has been tracked across 102 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 4 MG TABLET?
Since Sep 11, 2024, the NADAC for METHYLPREDNISOLONE 4 MG TABLET has ranged from a low of $0.1105 (Nov 20, 2024) to a high of $0.1634 (Sep 11, 2024), with a median of $0.1413 per EA.
Are there cheaper alternatives to METHYLPREDNISOLONE 4 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPREDNISOLONE 4 MG DOSEPK, is $0.1155 per EA — about 7% below METHYLPREDNISOLONE 4 MG TABLET.
Who manufactures METHYLPREDNISOLONE 4 MG TABLET?
METHYLPREDNISOLONE 4 MG TABLET (NDC 62135076001) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.